Ultrafast selective quantification of methotrexate in human plasma by high-throughput MALDI-isotope dilution mass spectrometry

Papers of special note have been highlighted as: ▪ of interest

Bibliography

• 1  Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N. Engl. J. Med.309(18),1094–1104 (1983).
  Medline CASGoogle Scholar
• 2  Warren RB, Chalmers RJ, Griffiths CE, Menter A. Methotrexate for psoriasis in the era of biological therapy. Clin. Expl Dermatol.33(5),551–554 (2008).
  Medline CASGoogle Scholar
• 3  Luqmani R, Hennell S, Estrach C et al. British Society for Rheumatology and British Health Professionals in rheumatology guideline for the management of rheumatoid arthritis (the first two years). Rheumatology45(9),1167–1169 (2006).
  Medline CASGoogle Scholar
• 4  Pincus T, Sokka T. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients? Rheumatology45(5),497–499 (2006).
  Medline CASGoogle Scholar
• 5  Lennard L. Therapeutic drug monitoring of cytotoxic drugs. Br. J. Clin. Pharmacol.52(Suppl. 1),75S–87S (2001).
  Medline CASGoogle Scholar
• 6  Li H, Luo W, Zeng Q, Lin Z, Luo H, Zhang Y. Method for the determination of blood methotrexate by high performance liquid chromatography with online post-column electrochemical oxidation and fluorescence detection. J. Chromatogr. B Analy. Technol. Biomed. Life Sci.845(1),164–168 (2007).▪ [6–22] describe common analytical techniques for methotrexate determination in biological matrices.
  Medline CASGoogle Scholar
• 7  Albertioni F, Pettersson B, Beck O, Rask C, Seideman P, Peterson C. Simultaneous quantitation of methotrexate and its two main metabolites in biological fluids by a novel solid-phase extraction procedure using high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl.665(1),163–170 (1995).
  Medline CASGoogle Scholar
• 8  Nelson JA, Harris Ba, Decker WJ, Farquhar D. Analysis of methotrexate in human plasma by high-pressure liquid chromatography with fluorescence detection. Cancer Research37(11),3970–3973 (1977).
  Medline CASGoogle Scholar
• 9  Belz S, Frickel C, Wolfrom C, Nau H, Henze G. High-performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid. J. Chromatogr. B Biomed. Appl.661(1),109–118 (1994).
  Medline CASGoogle Scholar
• 10  Barbieri A, Sabatini L, Indiveri P, Bonfiglioli R, Lodi V, Violante FS. Simultaneous determination of low levels of methotrexate and cyclophosphamide in human urine by micro liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom.20(12),1889–1893 (2006).
  Medline CASGoogle Scholar
• 11  Przybylski M, Preiss J, Dennebaum R, Fischer J. Identification and quantitation of methotrexate and methotrexate metabolites in clinical high-dose therapy by high pressure liquid chromatography and field desorption mass spectrometry. Biomed. Mass Spectrometry9(1),22–32 (1982).
  Medline CASGoogle Scholar
• 12  Turci R, Fiorentino ML, Sottani C, Minoia C. Determination of methotrexate in human urine at trace levels by solid phase extraction and high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom.14(3),173–179 (2000).
  Medline CASGoogle Scholar
• 13  Kuo Cy, Wu HL, Kou Hs, Chiou SS, Wu DC, Wu SM. Simultaneous determination of methotrexate and its eight metabolites in human whole blood by capillary zone electrophoresis. J. Chromatogr. A1014(1–2),93–101 (2003).
  Medline CASGoogle Scholar
• 14  Hayashi H, Fujimaki C, Tsuboi S, Matsuyama T, Daimon T, Itoh K. Application of fluorescence polarization immunoassay for determination of methotrexate-polyglutamates in rheumatoid arthritis patients. Tohoku J. Exp. Med.215(1),95–101 (2008).
  Medline CASGoogle Scholar
• 15  Paxton JW, Rowell FJ. A rapid, sensitive and specific radioimmunoassay for methotrexate. Clinica Chimica Acta80(3),563–572 (1977).
  Medline CASGoogle Scholar
• 16  Hendel J, Sarek LJ, Hvidberg EF. Rapid radioimmunoassay for methotrexate in biological fluids. Clin. Chem.22(6),813–816 (1976).
  Medline CASGoogle Scholar
• 17  Stout M, Ravindranath Y, Kauffman R. High-performance liquid chromatographic assay for methotrexate utilizing a cold acetonitrile purification and separation of plasma or cerebrospinal fluid. J. Chromatogr.342(2),424–430 (1985).
  Medline CASGoogle Scholar
• 18  Steinborner S, Henion J. Liquid–liquid extraction in the 96-well plate format with SRM LC/MS quantitative determination of methotrexate and its major metabolite in human plasma. Anal. Chem.71(13),2340–2345 (1999).
  Medline CASGoogle Scholar
• 19  Cociglio M, Hillaire-Buys D, Alric C. Determination of methotrexate and 7-hydroxymethotrexate by liquid chromatography for routine monitoring of plasma levels. J. Chromatogr. B Biomed. Appl.674(1),101–110 (1995).
  Medline CASGoogle Scholar
• 20  Mccrudden EA, Tett SE. Improved high-performance liquid chromatography determination of methotrexate and its major metabolite in plasma using a poly(styrene-divinylbenzene) column. J. Chromatogr.721(1),87–92 (1999).
  CASGoogle Scholar
• 21  Emara S, Askal H, Masujima T. Rapid determination of methotrexate in plasma by high-performance liquid chromatography with online solid-phase extraction and automated precolumn derivatization. Biomed. Chromatogr.12(6),338–342 (1998).
  Medline CASGoogle Scholar
• 22  Aboleneen H, Simpson J, Backes D. Determination of methotrexate in serum by high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl.681(2),317–322 (1996).
  Medline CASGoogle Scholar
• 23  Meesters RJ, Cornelissen R, Van Klaveren RJ et al. A new ultrafast and high-throughput mass spectrometric approach for the therapeutic drug monitoring of the multi-targeted anti-folate pemetrexed in plasma from lung cancer patients. Anal. Bioanal. Chem.398,2943–2948 (2010).▪▪ [23–34] describe the use of MALDI-triple quadrupole mass spectrometry in biological application.
  Medline CASGoogle Scholar
• 24  Wagner M, Varesio E, Hopfgartner G. Ultra-fast quantitation of saquinavir in human plasma by matrix-assisted laser desorption/ionization and selected reaction monitoring mode detection. J. Chromatog.872(1–2),68–76 (2008).
  CASGoogle Scholar
• 25  Volmer Da, Sleno L, Bateman K et al. Comparison of MALDI to ESI on a triple quadrupole platform for pharmacokinetic analyses. Anal. Chem.79(23),9000–9006 (2007).
  Medline CASGoogle Scholar
• 26  Meesters RJ, Van Kampen JJ, Reedijk ML et al. Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots. Anal. Bioanal. Chem.398(1),319–328 (2010).
  Medline CASGoogle Scholar
• 27  Van Kampen JJ, Reedijk ML, Burgers PC et al. Ultrafast analysis of plasma and intracellular levels of HIV protease inhibitors in children. a clinical application of MALDI mass spectrometry. PloS One5(7),e11409 (2010).
  MedlineGoogle Scholar
• 28  Meesters RJ, Van Kampen JJ, Scheuer RD, van der Ende ME, Gruters RA, Luider TM. Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilutionMALDI-triple quadrupole tandem mass spectrometry. J. Mass Spectrom.46,282–289 (2011).
  Medline CASGoogle Scholar
• 29  Hatsis P, Brombacher S, Corr J, Kovarik P, Volmer DA. Quantitative analysis of small pharmaceutical drugs using a high repetition rate laser matrix-assisted laser/desorption ionization source. Rapid Commun. Mass Spectrom.17(20),2303–2309 (2003).
  Medline CASGoogle Scholar
• 30  Sleno L, Volmer DA. Some fundamental and technical aspects of the quantitative analysis of pharmaceutical drugs by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom.19(14),1928–1936 (2005).
  Medline CASGoogle Scholar
• 31  Porta T, Grivet C, Knochenmuss R, Varesio E, Hopfgartner G. Alternative CHCA-based matrices for the analysis of low molecular weight compounds by UV-MALDI-tandem mass spectrometry. J. Mass Spectrom.46(2),144–152 (2011).
  Medline CASGoogle Scholar
• 32  Rathore R, Corr J, Scott G, Vollmerhaus P, Greis KD. Development of an inhibitor screening platform via mass spectrometry. J. Biomol. Screen.13(10),1007–1013 (2008).
  Medline CASGoogle Scholar
• 33  Wolfe RR, Chinkes DL. Determination of isotope enrichment. In: Isotope Tracers in Metabolic Research – Principles and Practice of Kinetic Analysis (Second Edition). John Wiley & Sons, Hoboken, NJ, USA, 93–113 (2005).
  Google Scholar
• 34  Van Kampen JJ, Burgers Pc, Gruters RA et al. Quantitative analysis of antiretroviral drugs in lysates of peripheral blood mononuclear cells using MALDI-triple quadrupole mass spectrometry. Anal. Chem.80(13),4969–4975 (2008).
  Medline CASGoogle Scholar
• 35  Farquhar D, Loo TL. Synthesis and biologic evaluation of 7-hydroxymethotrexate, 7-methylaminopterin, and 7-methylmethotrexate. J. Med. Chem.15(5),567–569 (1972).
  Medline CASGoogle Scholar
• 36  Altman DG, Bland Jm. Measurements in medicine: the analysis of method comparison studies. The Statistician32(3),307–317 (1983).
  Google Scholar
• 37  Bland JM, Altman DG. Comparing methods of measurement. Why plotting difference against standard method is misleading. Lancet346(8982),1085–1087 (1995).
  Medline CASGoogle Scholar
• 38  Rubino FM. Separation methods for methotrexate, its structural analogues and metabolites. J. Chromatogr. B Biomed. Sci. Appl.764(1–2),217–254 (2001).
  Medline CASGoogle Scholar
• 39  Khoo SH, Gibbons SE, Back DJ. Therapeutic drug monitoring as a tool in treating HIV infection. AIDS15(Suppl. 5),S171–S181 (2001).
  Medline CASGoogle Scholar
• 40  Erttmann R, Bielack S, Landbeck G. 7-Hydroxy-methotrexate and clinical toxicity following high-dose methotrexate therapy. J. Cancer Res. Clin. Oncol.109(1),86–88 (1985).
  Medline CASGoogle Scholar
• 101  CDER. Center for Drug Evaluation and Research. Guidance for Industry. Bioanalytical Method Validation (2001). www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf
  Google Scholar